Methods for protection from toxicity of alpha emitting elements during radioimmunotherapy

Details for Australian Patent Application No. 2004273775 (hide)

Owner Sloan-Kettering Institute for Cancer Research

Inventors Scheinberg, David; Jaggi, Jaspreet; McDevitt, Michael R.

Agent Callinan

Pub. Number AU-B-2004273775

PCT Pub. Number WO2005/028021

Priority 60/457,503 25.03.03 US

Filing date 23 March 2004

Wipo publication date 31 March 2005

Acceptance publication date 8 October 2009

International Classifications

A61K 51/00 (2006.01) Preparations containing radioactive substances for use in therapy or testing

A61K 36/14 (2006.01) Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

A61K 39/44 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies bound to carriers

A61K 51/12 (2006.01) Preparations containing radioactive substances for use in therapy or testing - characterised by a special physical form, e.g. emulsion, microcapsules, liposomes

C07F 5/00 (2006.01) Compounds containing elements of the 3rd Group of the Periodic System

Event Publications

27 October 2005 PCT application entered the National Phase

  PCT publication WO2005/028021 Priority application(s): WO2005/028021

8 October 2009 Application Accepted

  Published as AU-B-2004273775

12 November 2009 Application for Amendment

  The nature of the amendment is as shown in the statement(s) filed 15 Oct 2009. Address for service in Australia - Callinans 1193 Toorak Road Camberwell VIC 3124

4 March 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 15 Oct 2009

11 March 2010 Standard Patent Sealed

20 October 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004273776-Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus

2004273773-Methods for treatment of HIV or malaria using combinations of chloroquine and protease inhibitors